Dear Colleagues,

Vulvodynia is a vulvar discomfort that occurs in the absence of any specific, clinically identifiable disorder. Provoked vestibulodynia is the prevalent subtype of vulvodynia, and 12% of women are afflicted by this pathology at least once in their lifetime. Provoked vestibulodynia is a very common form of dyspareunia in both premenopausal and postmenopausal women, and is occasionally associated with other systemic diseases. It is a variegated, chronic pain condition of unspecified etiology. It has a significant impact on sexual activity and quality of life. Few therapies have shown to be effective for the treatment of vulvodynia. Technological and pharmacological innovations, have resulted in more precise and tailored therapy. This Special Issue will focus on the latest therapeutic strategies for this pathology.

Dr. Guglielmo Stabile
Guest Editor